GLAMOR-PM (Glimepiride, Metformin, and Pioglitazone Tablets): Uses, MOA, Benefits, and Recommended Dosage

  • Post category:Blog
  • Post comments:0 Comments
  • Reading time:7 mins read
GLAMOR-PM (Glimepiride, Metformin, and Pioglitazone Tablets)


GLAMOR-PM, a breakthrough formulation from Invision Medi Sciences, combines the synergistic effects of Glimepiride, Metformin Hydrochloride (SR), and Pioglitazone Hydrochloride to offer comprehensive management for individuals with type 2 diabetes. This guide explores the multifaceted approach of GLAMOR-PM in regulating blood sugar levels and improving insulin sensitivity.

Triple Action for Diabetes Control:

GLAMOR-PM leverages the combined benefits of Glimepiride, Metformin Hydrochloride (SR), and Pioglitazone Hydrochloride to address various aspects of diabetes pathology. Learn how each component works synergistically to achieve optimal glycemic control and metabolic balance.

Indications for GLAMOR-PM:

  1. Type 2 Diabetes Mellitus Management: GLAMOR-PM is indicated for individuals requiring pharmacological intervention to control blood sugar levels and improve insulin sensitivity.
  2. Triple Therapy: It serves as an adjunct to diet and exercise in patients inadequately controlled on dual therapy or those requiring triple therapy.

Key Benefits of GLAMOR-PM:

  1. Glucose Regulation: Glimepiride stimulates insulin secretion, Metformin Hydrochloride (SR) improves insulin sensitivity and reduces hepatic glucose production, while Pioglitazone Hydrochloride enhances peripheral insulin sensitivity, collectively promoting better blood sugar control.
  2. Cardiometabolic Benefits: Pioglitazone’s additional benefits include improving lipid profiles and reducing cardiovascular risk factors, providing comprehensive cardiometabolic benefits.

Recommended Dosage:

The recommended dosage of GLAMOR-PM is individualized based on the patient’s glycemic status and tolerance. Healthcare providers typically initiate therapy with one tablet daily, adjusting the dose gradually to achieve optimal glycemic control.

Potential Side Effects:

While generally well-tolerated, GLAMOR-PM may cause side effects such as:

  • Hypoglycemia: Glimepiride’s insulin secretagogue effect may lead to hypoglycemia, especially in susceptible individuals.
  • Gastrointestinal Disturbances: Metformin Hydrochloride (SR) may cause gastrointestinal symptoms such as nausea, vomiting, or diarrhea.

Essential Information:

  • Regular Monitoring: Regular monitoring of blood glucose levels, renal function, and signs of heart failure is recommended during GLAMOR-PM therapy.
  • Patient Counseling: Patients should be counseled regarding the potential risks and benefits of GLAMOR-PM, including adherence to dietary and lifestyle modifications.


GLAMOR-PM exemplifies Invision Medi Sciences’ commitment to providing comprehensive solutions for diabetes management. By combining Glimepiride, Metformin Hydrochloride (SR), and Pioglitazone Hydrochloride, GLAMOR-PM offers a multifaceted approach to achieving optimal glycemic control and cardiometabolic health.

Related Combinations:

Explore our range of diabetes management solutions at Invision Medi Sciences.

GLAMOR-PM: Empowering individuals with triple-action diabetes management.


What is the role of Glimepiride in GLAMOR-PM tablets?

Glimepiride acts as an insulin secretagogue, stimulating insulin release from pancreatic beta cells to help lower blood sugar levels in individuals with type 2 diabetes.

How does Metformin Hydrochloride (SR) contribute to the effectiveness of GLAMOR-PM?

Metformin Hydrochloride (SR) improves insulin sensitivity, reduces hepatic glucose production, and enhances peripheral glucose uptake, assisting in better glycemic control.

What are the benefits of Pioglitazone Hydrochloride in GLAMOR-PM tablets?

Pioglitazone Hydrochloride enhances peripheral insulin sensitivity and reduces insulin resistance, offering comprehensive cardiometabolic benefits beyond glycemic control.

Are there any specific monitoring requirements for individuals using GLAMOR-PM tablets?

Regular monitoring of blood glucose levels, renal function, and signs of heart failure is recommended during GLAMOR-PM therapy to ensure safety and efficacy.

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.